Cefotaxime-resistant Citrobacter freundii in isolates from blood in a tertiary teaching hospital in Northern Taiwan

Journal of Infection

Volumn 55, Issue 4, 2007, Pages 363-368

  Liu, Chang Pan ^a,b   Weng, Li Chuan ^a   Tseng, Hsiang Kuang ^a   Wang, Nai Yu ^a   Lee, Chun Ming ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b Mackay College of Nursing and Medicine   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bloodstream infection; Citrobacter freundii; CTX M 27; SHV 12

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL DNA; BETA LACTAMASE AMPC; CARBAPENEM; CEFEPIME; CEFOTAXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; TEICOPLANIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CITROBACTER FREUNDII; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG CHOICE; FEMALE; GENE IDENTIFICATION; GRAM NEGATIVE SEPSIS; HOSPITAL INFECTION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; TAIWAN; TEACHING HOSPITAL; WOUND INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEFOTAXIME; CITROBACTER FREUNDII; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALS, TEACHING; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TAIWAN;

EID: 34548506748     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.04.010     Document Type: Article

References (24)

1. Pitout J.D.D., Sanders C.C., and Sanders Jr. W.E. Antimicrobial resistance with focus on β-lactam resistance in Gram-negative bacilli. Am J Med 103 (1997) 51-59
2. Livermore D.M. β-lactamase-mediated resistance and opportunities for its control. J Antimicrob Chemother 41 Suppl. (1998) D25-D41
3. Knothe H., Shah P., Krcmery V., Antal M., and Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsilla pneumoniae and Serratia marcescens. Infection 11 (1983) 315-317
4. Kliebe C., Nies B.A., Meyer J.F., Tolxdorff-Neutzling R.M., and Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 28 (1985) 302-307
5. Jacoby G.A., and Munoz-Price L.S. The new β-lactamases. N Engl J Med 352 (2005) 380-391
6. Liu C.P., Wang N.Y., Lee C.M., Weng L.C., Tseng H.K., Liu C.W., et al. Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: risk factors for and prevalence of SHV-12 in multiresistant isolates in a medical centre. J Hosp Infect 58 (2004) 63-77
7. Li W.C., Huang F.Y., Liu C.P., Weng L.C., Wang N.Y., Chiu N.C., et al. Ceftriaxone resistance of nontyphoidal Salmonella enterica isolates in northern Taiwan attributable to production of CTX-M-14 and CMY-2 β-lactamases. J Clin Microbiol 43 (2005) 3237-3243
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S16 (2006), CLSI, Wayne, PA
9. Ko W.C., Lee H.C., Chiang S.R., Yang J.J., Wu J.J., Lu C.L., et al. In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain. J Antimicrob Chemother 53 (2004) 393-395
10. Oliver A., Perez-Vazquez M., Martinez-Ferrer M., Baquero F., Rafael L.D., and Canton R. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different β-lactam resistance phenotypes. Antimicrob Agents Chemother 43 (1999) 302-307
11. Weng L.C., Liaw G.J., Wang N.Y., Wang S.F., Lee C.M., Huang F.Y., et al. Investigation of an outbreak of Pseudomonas putida using antimicrobial susceptibility patterns, pulsed-field gel electrophoresis of genomic DNA and restriction fragment length polymorphism of PCR-amplified rRNA operons. J Microbiol Immunol Infect 32 (1999) 187-193
12. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
13. Sinnett D., Richer C., and Baccichet A. Isolation of stable bacterial artificial chromosome DNA using a modified alkaline lysis method. BioTechniques 24 (1998) 752-754
14. Kim B.N., Woo J.H., Ryu J., and Kim Y.S. Resistance to extended-spectrum cephalosporin and mortality in patients with Citrobacter freundii bacteremia. Infection 4 (2003) 202-207
15. Thomson K.S. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis 7 (2001) 333-336
16. Thomson K.S., Moland E.S., and Sanders C.C. Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for β-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. Antimicrob Agents Chemother 43 (1999) 1393-1400
17. Thomson K.S., and Moland E.S. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 45 (2001) 3548-3554
18. Stürenburg E., and Mack D. Extended-spectrum β-lactamase implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 47 (2003) 273-295
19. Arakawa Y., Shibata N., Shibayama K., Kurokawa H., Yagi T., Fujiwara H., et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol 38 (2000) 40-43
20. Bonnet R., Sampaio L.M., Labia R., Champs C.D., Sirot D., Chanal C., et al. A novel CTX-M β-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob Agents Chemother 44 (2000) 1936-1942
21. Papperell C., Kus J.V., Gardam M.A., Humar A., and Burrows L.L. Low-virulence C. freundii species encode resisitance to multiple antimicrobials. Antimicrob Agents Chemother 118 (2003) 29-32
22. Abdalhamid B., Pitout J.D.D., Moland E.S., and Hanson N.D. Community-onset disease caused by C. freundii producing a novel CTX-M β-lactamase, CTX-M-30, in Canada. Antimicrob Agents Chemother 48 (2004) 4435-4437
23. Paterson D., Rossi F., Baquero F., Hsueh P.R., Woods G.L., Satishchandran V., et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother 55 (2005) 965-973
24. Ramphal R., and Ambrose P.G. Extended-spectrum β-lactamases and clinical outcomes: current data. Clin Infect Dis 42 (2006) S164-S172